Cargando…
CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway
BACKGROUND: As a rapid‐progressing tumor, breast malignant phyllodes tumors (PTs) are challenged by the lack of effective therapeutic strategies and suitable prognostic markers. This study aimed to clarify the role and mechanism of CD146 on promoting PTs malignant progression, and to identify a nove...
Autores principales: | Chen, Jiewen, Xu, Qingji, Liu, Dan, Li, Xun, Guo, Mingyan, Chen, Xuehui, Liao, Jianyou, Lei, Rong, Li, Wende, Huang, Hongyan, Saw, Phei Er, Song, Erwei, Yan, Xiyun, Nie, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631482/ https://www.ncbi.nlm.nih.gov/pubmed/37856423 http://dx.doi.org/10.1002/cac2.12495 |
Ejemplares similares
-
Structure basis for AA98 inhibition on the activation of endothelial cells mediated by CD146
por: Chen, Xuehui, et al.
Publicado: (2021) -
CD146, from a melanoma cell adhesion molecule to a signaling receptor
por: Wang, Zhaoqing, et al.
Publicado: (2020) -
Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022) -
Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2
por: Schmoker, Anna M., et al.
Publicado: (2017) -
Transforming Tea Catechins into Potent Anticancer Compound: Analysis of Three Boronated-PEG Delivery System
por: Guo, Mingyan, et al.
Publicado: (2021)